This Article Full Text Full Text (PDF) All Versions of this Article: 106/15/1991    most recent 01.CIR.0000032004.56585.2Av1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murakoshi, N. Articles by Yamaguchi, I. Search for Related Content PubMed PubMed Citation Articles by Murakoshi, N. Articles by Yamaguchi, I. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Remodeling

(Circulation. 2002;106:1991.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Vascular Endothelin-B Receptor System In Vivo Plays a Favorable Inhibitory Role in Vascular Remodeling After Injury Revealed by Endothelin-B Receptor–Knockout Mice

Nobuyuki Murakoshi, MD; Takashi Miyauchi, MD, PhD; Yoshihiko Kakinuma, MD, PhD; Takashi Ohuchi, MD, PhD; Katsutoshi Goto, PhD; Masashi Yanagisawa, MD, PhD; Iwao Yamaguchi, MD, PhD

From the Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine (N.M., T.M., Y.K., I.Y.), and the Department of Pharmacology, Institute of Basic Medical Sciences (K.G.), University of Tsukuba, Ibaraki, Japan, and the University of Texas Southwestern Medical Center (T.O., M.Y.), Dallas, Tex.

Correspondence to Takashi Miyauchi, MD, PhD, Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan. E-mail t-miyauc{at}md.tsukuba.ac.jp

Background— Two subtypes of endothelin (ET) receptors, ET_A and ET_B, are distributed in vascular smooth muscle cells to cause contraction and proliferation. Vascular endothelial cells express only ET_B receptors, which cause NO release. Although ET_A receptor blockade is reported to be effective in ameliorating vascular remodeling, there is no report on the long-term effect of ET_B receptor blockade on vascular remodeling after injury.

Methods and Results— ET_B receptor–knockout (KO) mice, which were genetically rescued from lethal intestinal aganglionosis, and wild-type (WT) mice underwent complete ligation of the right common carotid artery, ie, a blood flow cessation model of vascular remodeling. Fourteen days after ligation, the intimal area, the ratio of intimal to medial areas, and the stenotic ratio in the ligated artery of KO mice were significantly increased compared with those of WT mice. The expression level of ET-1 mRNA in the ligated artery of KO mice was increased similarly to that of WT mice, whereas tissue NO_x levels in lesions of KO mice were significantly lower than those of WT mice. Long-term treatment with the ET_A receptor antagonist TA-0201 (0.5 mg · kg^-1 · d^-1) significantly ameliorated vascular stenosis in both groups. Long-term treatment with the ET_B receptor antagonist A-192621 (30 mg · kg^-1 · d^-1) worsened vascular remodeling in WT mice.

Conclusions— We demonstrated that inhibition of the ET_B receptor system is harmful for vascular remodeling after injury, the mechanism of which is partly attributed to decreased NO release, in KO mice. These results suggest that the overall effect of vascular ET_B receptors is antiproliferative in the injured artery.

Key Words: endothelin • receptors • genes • remodeling

This article has been cited by other articles:

				K. Kitada, N. Yui, C. Matsumoto, T. Mori, M. Ohkita, and Y. Matsumura Inhibition of Endothelin ETB Receptor System Aggravates Neointimal Hyperplasia after Balloon Injury of Rat Carotid Artery J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 998 - 1004. [Abstract] [Full Text] [PDF]

				F. Syeda, E. Tullis, A. S. Slutsky, and H. Zhang Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2769 - H2774. [Abstract] [Full Text] [PDF]

				K. Sachidanandam, V. Portik-Dobos, A. K. Harris, J. R. Hutchinson, E. Muller, M. H. Johnson, and A. Ergul Evidence for Vasculoprotective Effects of ETB Receptors in Resistance Artery Remodeling in Diabetes Diabetes, November 1, 2007; 56(11): 2753 - 2758. [Abstract] [Full Text] [PDF]

				H. A. Ghofrani, R. Voswinckel, F. Reichenberger, N. Weissmann, R. T. Schermuly, W. Seeger, and F. Grimminger Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies Cardiovasc Res, October 1, 2006; 72(1): 30 - 40. [Abstract] [Full Text] [PDF]

				Y. Zhou, S. Mitra, S. Varadharaj, N. Parinandi, J. L. Zweier, and N. A. Flavahan Increased Expression of Cyclooxygenase-2 Mediates Enhanced Contraction to Endothelin ETA Receptor Stimulation in Endothelial Nitric Oxide Synthase Knockout Mice Circ. Res., June 9, 2006; 98(11): 1439 - 1445. [Abstract] [Full Text] [PDF]

				E. Grantcharova, H. P. Reusch, S. Grossmann, J. Eichhorst, H.-W. Krell, M. Beyermann, W. Rosenthal, and A. Oksche N-Terminal Proteolysis of the Endothelin B Receptor Abolishes Its Ability to Induce EGF Receptor Transactivation and Contractile Protein Expression in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1288 - 1296. [Abstract] [Full Text] [PDF]

				C. Ko, M. C. Gieske, L. Al-Alem, Y. Hahn, W. Su, M. C. Gong, M. Iglarz, and Y. Koo Endothelin-2 in Ovarian Follicle Rupture Endocrinology, April 1, 2006; 147(4): 1770 - 1779. [Abstract] [Full Text] [PDF]

				D. D. Ivy, I. F. McMurtry, K. Colvin, M. Imamura, M. Oka, D.-S. Lee, S. Gebb, and P. L. Jones Development of Occlusive Neointimal Lesions in Distal Pulmonary Arteries of Endothelin B Receptor-Deficient Rats: A New Model of Severe Pulmonary Arterial Hypertension Circulation, June 7, 2005; 111(22): 2988 - 2996. [Abstract] [Full Text] [PDF]

				Y. Li, T. Minamino, O. Tsukamoto, T. Yujiri, Y. Shintani, K.-i. Okada, Y. Nagamachi, M. Fujita, A. Hirata, S. Sanada, et al. Ablation of MEK Kinase 1 Suppresses Intimal Hyperplasia by Impairing Smooth Muscle Cell Migration and Urokinase Plasminogen Activator Expression in a Mouse Blood-Flow Cessation Model Circulation, April 5, 2005; 111(13): 1672 - 1678. [Abstract] [Full Text] [PDF]

				S. C. Wolf, G. Sauter, H.-P. Rodemann, T. Risler, and B. R. Brehm Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism Nephrol. Dial. Transplant., February 1, 2005; 20(2): 312 - 318. [Abstract] [Full Text] [PDF]

				D. Langleben, A. M. Hirsch, E. Shalit, L. Lesenko, and R. J. Barst Sustained Symptomatic, Functional, and Hemodynamic Benefit With the Selective Endothelin-A Receptor Antagonist, Sitaxsentan, in Patients With Pulmonary Arterial Hypertension: A 1-Year Follow-up Study Chest, October 1, 2004; 126(4): 1377 - 1381. [Abstract] [Full Text] [PDF]

				G. Guruli, B. R. Pflug, S. Pecher, V. Makarenkova, M. R. Shurin, and J. B. Nelson Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops Blood, October 1, 2004; 104(7): 2107 - 2115. [Abstract] [Full Text] [PDF]

				Y. Zhou, W. P. Dirksen, J. L. Zweier, and M. Periasamy Endothelin-1-induced responses in isolated mouse vessels: the expression and function of receptor types Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H573 - H578. [Abstract] [Full Text] [PDF]

				S. Liu, R. T. Premont, C. D. Kontos, J. Huang, and D. C. Rockey Endothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein {beta}{gamma} Subunit Signaling to Protein Kinase B/Akt J. Biol. Chem., December 12, 2003; 278(50): 49929 - 49935. [Abstract] [Full Text] [PDF]

				Y. Zhou, W. P. Dirksen, G. J. Babu, and M. Periasamy Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2797 - H2803. [Abstract] [Full Text] [PDF]

				K.-H. Ding, Q. Zhong, and C. M. Isales Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1 Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E390 - E396. [Abstract] [Full Text] [PDF]